Author:
Ikeda Toshimasa,Yamada Kentaro,Ogawa Ryo,Takai Yoshiki,Kaneko Kimihiko,Misu Tatsuro,Kamimoto Kaoru,Matsukawa Noriyuki,Yoshida Mari
Funder
Bayer Schering
Biogen Idec
AMED
JSPS KAKENHI
Ministry of Health, Labour and Welfare, Japan
Tohoku University
Kagoshima University
Subject
Neurology (clinical),Neurology
Reference10 articles.
1. Myelin oligodendrocyte glycoprotein: deciphering a target in inflammatory demyelinating diseases;Peschl;Front. Immunol.,2017
2. MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy;Ogawa;Neurol. Neuroimmunol. NeuroInflamm.,2017
3. Inflammatory demyelination without astrocyte loss in MOG antibody-positive NMOSD;Wang;Neurology,2016
4. Fulminant demyelinating encephalomyelitis: insights from antibody studies and neuropathology;Di Pauli;Neurol. Neuroimmunol. NeuroInflamm.,2015
5. ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports;Körtvélyessy;Neurol. Neuroimmunol. NeuroInflamm.,2017